Hudson Bay Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.36M | Sell |
465,000
-100,000
| -18% | -$938K | 0.01% | 410 |
|
|
2025
Q1 | $4.02M | Buy |
565,000
+52,700
| +10% | +$375K | 0.01% | 396 |
|
|
2024
Q4 | $5.97M | Buy |
512,300
+177,300
| +53% | +$2.07M | 0.02% | 334 |
|
|
2024
Q3 | $6.88M | Buy |
335,000
+60,000
| +22% | +$1.23M | 0.03% | 251 |
|
|
2024
Q2 | $6.15M | Buy |
275,000
+27,700
| +11% | +$620K | 0.03% | 269 |
|
|
2024
Q1 | $6.8M | Buy |
247,300
+9,800
| +4% | +$270K | 0.04% | 198 |
|
|
2023
Q4 | $7.24M | Buy |
237,500
+52,300
| +28% | +$1.59M | 0.05% | 203 |
|
|
2023
Q3 | $5.86M | Buy |
185,200
+25,200
| +16% | +$797K | 0.05% | 213 |
|
|
2023
Q2 | $6.52M | Sell |
160,000
-40,000
| -20% | -$1.63M | 0.05% | 219 |
|
|
2023
Q1 | $7.45M | Sell |
200,000
-8,100
| -4% | -$302K | 0.06% | 191 |
|
|
2022
Q4 | $7.26M | Buy |
208,100
+193,100
| +1,287% | +$6.74M | 0.07% | 219 |
|
|
2022
Q3 | $839K | Sell |
15,000
-55,300
| -79% | -$3.09M | 0.01% | 826 |
|
|
2022
Q2 | $3.64M | Buy |
70,300
+5,900
| +9% | +$305K | 0.03% | 534 |
|
|
2022
Q1 | $4.68M | Buy |
64,400
+34,400
| +115% | +$2.5M | 0.06% | 389 |
|
|
2021
Q4 | $3.55M | Buy |
30,000
+12,500
| +71% | +$1.48M | 0.04% | 476 |
|
|
2021
Q3 | $2.35M | Buy |
+17,500
| New | +$2.35M | 0.03% | 571 |
|